Monday, August 31, 2026

Nikola Stock Plunges Over 28% In Recent 10 Sessions

ViaNews Editorial Team

December 12, 2023

Nikola Stock Plunges Over 28% In Recent 10 Sessions

(VIANEWS) - Nikola (NASDAQ:NKLA) shares have experienced an extraordinary 28.96% drop from EUR0.97 to EUR0.69 over just 10 sessions, according to 21:34 EST on Monday evening. This follows two consecutive losses; as such, the NASDAQ is down 0.2% at EUR14,375.62 following two gains of its own; Nikola's last close was EUR0.71, representing an 80.74% decline since its 52-week high of EUR3.71.

About Nikola

Nikola Corporation is a technology innovator and integrator specializing in energy and transportation solutions. Operating through two business units: Truck and Energy, Nikola Corporation develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) for use by trucking companies while Energy builds hydrogen fueling stations and provides charging solutions for FCEV customers as well as third-party customers. Established in 2015 in Phoenix, Arizona; Nikola works collaboratively with partners and suppliers to assemble, integrate, and commission its vehicles.

Yearly Analysis

Nikola's stock currently trades for EUR0.69, well below its 52-week high of EUR3.71 but above its low point of EUR0.52. Sales growth projections show a decrease of 21.7% this year but an expected rebound with 562.9% growth next year; EBITDA currently stands at 30.87. Given this information, it can be challenging to predict Nikola's stock accurately. A negative sales growth rate this year usually signals negative prospects for investors while its anticipated strong expansion could be seen as positive indicators. Still, investors should carefully evaluate other factors like financial health, management skills and industry trends before making investment decisions. Before making any investment decisions, potential investors may wish to conduct thorough due diligence on Nikola's financial statements, competitive landscape and overall market conditions. Furthermore, it would be beneficial for them to consult a financial advisor for tailored investment advice tailored specifically to individual circumstances and goals.

Technical Analysis

Nikola, a leading designer and manufacturer of zero-emission Class 8 trucks, has experienced an alarming decline in their stock prices recently. Nikola shares are currently trading at EUR0.81, significantly below both their 50-day moving average of EUR1.16 and 200-day moving average of EUR1.36. Nikola's recent stock price decline is not unexpected given its failure to live up to promises and meet production targets, in addition to financial issues and key personnel vacating. Investors remain concerned over Nikola's health. Nikola's stock, however, has shown signs of bullishness despite its bearish outlook. Today's volume was 128.16% higher than its average volume 68637200, suggesting significant interest in its shares. Nikola's volatility has also been on an upward trend, with its average intraday variation average for last week, month, and quarter being negative 9.67%, negative 1.79%, and positive 5.73% respectively; its highest amplitude of average volatility being 10.31% last week; 4.78% for month; and 5.73% for quarter. Nikola's stock has shown considerable volatility; however, according to the stochastic oscillator (a useful indicator of overbought and oversold conditions), its status was classified as overbought (>=80), suggesting it could be time for a correction. Nikola's stock price continues to fluctuate, and current market conditions and the company's difficulties suggest investors should use extreme caution before making investments in it. Investors must keep an eye on how Nikola performs and any developments that could alter its stock price in coming weeks and months.

Quarter Analysis

Nikola's sales growth is impressive with current quarter growth at 120.8% and next quarter growth estimated at 229%; however, estimated quarterly growth estimates range between 64.9% and 61.5% which may indicate slowing in future quarters. Overall, Nikola appears to be experiencing rapid expansion; however, investors should keep this growth in perspective and conduct extensive due diligence on its business model, competitive landscape, and finances to ascertain whether its current expansion path can continue over time.

Equity Analysis

Nikola has posted an earnings per share (EPS) figure of EUR-1.61 over its trailing 12 month earnings period, suggesting it may not be producing profits for shareholders. Furthermore, its return on equity over this timeframe was negative at -159.83% indicating its profitability isn't commensurate with equity invested by shareholders. As an investor it's essential to thoroughly investigate a company before making investment decisions; given Nikola's current financial performance may not appear promising to them, it may be wiser for them to proceed cautiously before considering making any commitment.

More news about Nikola (NKLA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com